Arca
Skip to content
Tools
Tools

Chronic cough

Drug research and approvals for chronic cough: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 21, 2026, 29 studies of chronic cough are recruiting on ClinicalTrials.gov, Health Canada has authorized 18 drug trials for it since 2013, and the EU has 1 authorised medicine for it.

  • Recruiting worldwide: 29
  • Trials authorized in Canada: 18
  • FDA orphan approvals: 0
  • EU medicines: 1

Recruiting now

Newest posted first, of 29 recruiting on ClinicalTrials.gov ↗

Drug pipeline

Each drug at the furthest stage it has reached for this condition, from ChEMBL's drug indications

Approved 1

Phase 1 or earlier 2

How its trials ended

119 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 34 whose ending is known, 65% met their primary endpoint, 9% missed it and 26% stopped early.

  • Completed, result not reported3832%
  • Ongoing2924%
  • Met its primary endpoint2218%
  • Status unknown1815%
  • Stopped: enrollment or feasibility43%
  • Missed its primary endpoint33%
  • Stopped: other or unclear33%
  • Stopped: lack of efficacy22%

Trials authorized in Canada

The 10 newest of 18; search them all in Canada trials
Sep 28, 2026A randomized, double-blind, placebo-controlled twelve-week fixed-dose study to evaluate the efficacy and safety of nalbuphine extended-release tablets for the…NalbuphineTrevi TherapeuticsPending
May 22, 2026A randomized, double-blind, placebo-controlled dose-ranging study to evaluate the efficacy and safety of nalbuphine extended-release tablets for the treatment…NalbuphineTrevi TherapeuticsOngoing
Nov 27, 2025A 2x2 factorial, randomized, open-label trial to evaluate neuromodulators and cough control therapy in patients with refractory or unexplained chronic cough:…Morphine / PregabalinMcMaster UniversityPending
Sep 3, 2025Understanding the role of airway mucus occlusions in Canadians with asthma, COPD and chronic cough (CANMUC)Hyperpolarized XENON-129McMaster UniversityPending
Feb 11, 2025A phase 3, 24-week, randomized, double-blind, placebo-controlled, parallelarm efficacy and safety study with open-label extension of BLU-5937 in adult…Camlipixant (GSK5464714, BLU-5937)BELLUS HealthOngoing
Sep 26, 2024A phase 2b, randomized, double-blind, placebo-controlled study to assess the efficacy, safety, and tolerability of taplucainium inhalation powder (NOC-110) in…Taplucainium (NOC-110/NTX-1175)Nocion TherapeuticsOngoing
Aug 21, 2023A randomized, double-blind, placebo-controlled, parallel, 4-arm dose ranging study of the safety and efficacy of nal er tablets for the treatment of cough in…NalbuphineTrevi TherapeuticsClosed
Aug 11, 2023A phase 2, double-blind, randomized, placebo-controlled, two-period crossover efficacy and safety study of nalbuphine er tablets for the treatment of…NalbuphineTrevi TherapeuticsClosed
Nov 16, 2022A phase 3, 52-week, randomized, double-blind, placebo-controlled, parallel-arm efficacy and safety study with open-label extension of BLU-5937 in adult…Camlipixant (BLU-5937)BELLUS HealthClosed
Mar 29, 2021Mepolizumab for the treatment of chronic cough with eosinophilic airways diseaseNucalaMcMaster UniversityPending

Medicines authorised in the EU

Newest first
AuthorisedMedicineHolderEPAR
Sep 15, 2023LyfnuaGefapixantMerck Sharp & Dohme B.V.EMA ↗

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.